EU Regulators Give Positive Opinion to Revolution Medicines Pancreatic Cancer Treatment
The European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion for Rasonque, also known generically as daraxonrasib, for adults.
Revolution Medicines said its pancreatic cancer treatment Rasonque received a positive opinion from European regulators. The European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion on the drug, known generically as daraxonrasib, for adults w…